A comparison of extrapyramidal symptoms in older outpatients treated with quetiapine or risperidone

Current Medical Research and Opinion
Jacobo E MintzerDennis E Sweitzer

Abstract

To compare the tolerability of quetiapine with risperidone in older outpatients. Post hoc analysis of a subset of older patients (aged 60-80; n = 92) from a randomized, 4-month, multicenter, open-label trial comparing quetiapine and risperidone in an outpatient setting. Participants had various neuropsychiatric disorders associated with psychosis as defined by criteria from the Diagnostic and Statistical Manual of Mental Disorders (4th edn). The main outcome measure was an extrapyramidal symptoms (EPS) checklist, used to assess motor symptoms, including parkinsonism, at baseline and after treatment. The Positive and Negative Syndrome Scale (PANSS) and the Clinical Global Impression scale were used to assess therapeutic efficacy. Substantial EPS (defined as EPS requiring a dosage adjustment or use of medication to reduce EPS) occurred less often with quetiapine (median dosage, 200 mg/day) than with risperidone (median dosage, 3 mg/day); odds ratio, 0.31 (P < 0.03). Quetiapine was also less likely than risperidone to cause akathisia or hypertonia. Both compounds produced comparable reductions in PANSS scores. Interpretation of findings in this report is limited by the open-label design of the study and the post hoc nature of this...Continue Reading

References

Jan 6, 2000·Current Medical Research and Opinion·B Green
Oct 26, 2000·Clinical Therapeutics·P N TariotI W Rak
Oct 29, 2000·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·V Dev, J Raniwalla
Mar 16, 2001·Expert Opinion on Pharmacotherapy·R C Love, M W Nelson
Mar 16, 2001·Expert Opinion on Pharmacotherapy·S Kasper, F Müller-Spahn
Jan 5, 2002·Journal of Clinical Psychopharmacology·J P HwangS J Tsai
Jan 17, 2002·Pharmacotherapy·Vicki L EllingrodStephan Arndt
Apr 17, 2002·Schizophrenia Research·Hülya ErbağciErdem Gümüşburun
Apr 26, 2002·European Psychiatry : the Journal of the Association of European Psychiatrists·R Bullock, S Libretto
Sep 2, 2003·International Journal of Geriatric Psychiatry·Philip D HarveyGeorges Gharabawi

❮ Previous
Next ❯

Citations

Dec 31, 2010·Indian Journal of Pharmacology·Ruchita ShahNidhi Malhotra
Mar 27, 2007·Journal of Affective Disorders·Caleb M AdlerStephen M Strakowski
Feb 14, 2007·The American Journal of Geriatric Pharmacotherapy·Rehan AzizRajesh R Tampi
May 10, 2006·Progress in Neuro-psychopharmacology & Biological Psychiatry·Akiko KobayashiYoshio Hirayasu
Jan 21, 2011·The Cochrane Database of Systematic Reviews·Katja KomossaStefan Leucht
Nov 20, 2013·The Cochrane Database of Systematic Reviews·Laila AsmalStefan Leucht
Nov 11, 2006·International Journal of Geriatric Psychiatry·Lorenz HilwerlingStefan Georg Schröder
Sep 1, 2007·Journal of Clinical Neurology·Jeong-Min KimManho Kim
Dec 24, 2005·Harvard Review of Psychiatry·Dilip V JesteCarl Salzman
Feb 18, 2012·The Cochrane Database of Systematic Reviews·Adib Essali, Ghassan Ali
Jul 7, 2005·International Journal of Geriatric Psychiatry

❮ Previous
Next ❯

Related Concepts

Related Feeds

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.